IONS - CIK 0000874015
The table below shows IONIS PHARMACEUTICALS INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$268.58M | -$500.95M | -$307.51M | -$274.37M | $30.80M | $35.89M |
| Capital expenditure | $51.44M | $45.28M | $23.80M | $15.72M | $11.96M | $35.12M |
| Investing cash flow | -$277.78M | -$134.03M | -$214.13M | -$262.64M | $194.91M | $274.48M |
| Dividends paid | - | - | - | - | - |
IONIS PHARMACEUTICALS INC reported operating cash flow of -$268.58M for fiscal year 2025. That is up 46.4% from -$500.95M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$112.11M (FY 2016) to -$268.58M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | $0.00 | $0.00 | $90.55M |
| Financing cash flow | $675.84M | $478.06M | $644.08M | -$55.30M | $245.93M | -$596.61M |